Use of capital raised through the listing to expand the business and strengthen its financial position
First written in FY2017-Q1. 28 of 30 entries say "Advanced", first in FY2017-Q2. Latest entry: FY2025-H1.
29 other companies' latest entry also says "Advanced".
- FY2025-H1AdvancedAnnual report
「1 April 2024 – 30 September 2024 (Note) 238,080 12,229,200 81,417 ¥921.521 million 81,417 ¥826.138 million (Note) Increase resulting from the exercise of stock acquisition rights.」
The exercise of stock acquisition rights resulted in the issuance of 238,080 shares and increased share capital and the capital reserve by ¥81.417 million each. Capital raising has continued since the listing. - FY2024-Q3AdvancedAnnual report
「Between 1 January 2024 and 31 January 2024, the exercise of stock acquisition rights increased the total number of issued shares by 12,000 and increased share capital and the capital reserve by ¥4.293 million each.」
After the quarter-end, the exercise of stock acquisition rights resulted in the issuance of 12,000 shares and increases in share capital and the capital reserve, and capital raising continued after the listing. - FY2024-Q2AdvancedAnnual report
「1 July 2023– 30 September 2023 14,400 11,891,440 4,443 ¥804.585 million 4,443 ¥709.201 million (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter, the exercise of stock acquisition rights resulted in the issuance of 14,400 shares and increased share capital and the capital reserve by ¥4.443 million each. Capital raising has continued since the listing. - FY2024-Q1AdvancedAnnual report
「Between 1 July 2023 and 31 July 2023, the exercise of stock acquisition rights increased the total number of issued shares by 2,400 and increased share capital and the capital reserve by ¥150,000 each.」
The issuance of shares through the exercise of stock acquisition rights and increases in share capital and the capital reserve continued after the quarter-end, and capital raising progressed after the listing. - FY2023-Q3AdvancedAnnual report
「Between 1 January 2023 and 31 January 2023, the exercise of stock acquisition rights increased the total number of issued shares by 12,000 and increased share capital and the capital reserve by ¥4.293 million each.」
Stock acquisition rights were exercised in January 2023 after the end of the third quarter, resulting in the issuance of 12,000 shares and increases in share capital and the capital reserve. - FY2023-Q2AdvancedAnnual report
「1 July 2022– 30 September 2022 (Note) 20,160 11,856,480 5,984 ¥795.078 million 5,984 ¥699.694 million (Note) Increase resulting from the exercise of stock acquisition rights.」
During the second quarter, the exercise of stock acquisition rights resulted in the issuance of 20,160 shares and increased share capital and the capital reserve by ¥5.984 million each. - FY2023-Q1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the first quarter, the exercise of stock acquisition rights resulted in the issuance of 2,320 shares and increased share capital and the capital reserve by ¥145,000 each. A further 19,200 shares were issued by the filing date, and capital raising is continuing. - FY2022AdvancedAnnual report
「This was mainly due to increases of ¥7.850 million each in share capital and capital surplus from the exercise of stock acquisition rights, and a ¥751.377 million increase in retained earnings from the recognition of net income attributable to owners of the parent and dividend payments, among other factors.」
During the fiscal year, the exercise of stock acquisition rights increased share capital and capital surplus by ¥7.850 million each, and capital raising continued since the listing. - FY2022-Q3AdvancedAnnual report
「1 October 2021–31 December 2021 (Note) 1,760 11,833,760 110 ¥788.934 million 110 ¥693.550 million (Note) Increase resulting from the exercise of stock acquisition rights.」
During the third quarter, the exercise of stock acquisition rights resulted in the issuance of 1,760 shares and increased share capital and the capital reserve by ¥110,000 each. Capital raising has continued since the listing. - FY2022-Q2AdvancedAnnual report
「1 July 2021–30 September 2021 (Note) 7,920 11,832,000 495 ¥788.824 million 495 ¥693.440 million」
The exercise of stock acquisition rights resulted in the issuance of 7,920 shares and increased share capital and the capital reserve by ¥495,000 each. - FY2022-Q1AdvancedAnnual report
「This was mainly due to dividend payments of ¥82.619 million, increases of ¥7.230 million each in share capital and capital surplus from the exercise of stock acquisition rights, and an ¥82.565 million increase in retained earnings from the recognition of net income attributable to owners of the parent of ¥163.332 million.」
During the first quarter, the exercise of stock acquisition rights increased share capital and capital surplus by ¥7.230 million each, and capital raising continued. - FY2021-Q3AdvancedAnnual report
「This was mainly due to increases of ¥29.282 million each in share capital and capital surplus through the exercise of stock acquisition rights and an increase of ¥381.073 million in retained earnings through the recognition of quarterly net income attributable to owners of the parent and the payment of dividends.」
During the nine-month period of the current fiscal year, the exercise of stock acquisition rights increased share capital and capital surplus by ¥29.282 million each, continuing capital raising after the listing. - FY2021-Q2AdvancedAnnual report
「1 July 2020–30 September 2020」
The exercise of stock acquisition rights resulted in the issuance of 84,080 shares and increased share capital and capital reserve by ¥26.135 million each. Capital raising after the listing continued. - FY2021-Q1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
From April to June 2020, 2,400 shares were issued through the exercise of stock acquisition rights, increasing share capital and capital reserve by ¥150 thousand each. In addition, the issuance of 44,960 shares in July 2020 and increases of ¥15.824 million each were reported, continuing capital raising. - FY2020AdvancedAnnual report
「This was mainly due to increases of ¥17.591 million each in share capital and capital surplus through the exercise of stock acquisition rights and, despite the payment of ¥57.416 million in dividends, an increase of ¥475.928 million in retained earnings from the recognition of net income attributable to owners of the parent of ¥533.345 million, among other factors.」
During the fiscal year, the exercise of stock acquisition rights increased share capital and capital surplus by ¥17.591 million each, continuing capital raising. - FY2020-Q3AdvancedAnnual report
「This resulted from the exercise of share acquisition rights.」
From October to December 2019, 106,720 shares were issued through the exercise of stock acquisition rights, increasing share capital and capital reserve by ¥6.670 million each. Capital raising after the listing continued. - FY2020-Q2AdvancedAnnual report
「1 July 2019–30 September 2019」
From July to September 2019, 46,640 shares were issued through the exercise of stock acquisition rights, increasing share capital and capital reserve by ¥9.056 million each. Capital raising after the listing continued. - FY2020-Q1AdvancedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
From April to June 2019, the exercise of stock acquisition rights increased the number of shares by 11,280, increasing share capital and capital reserve by ¥705 thousand each. In addition, the issuance of 37,600 shares in July 2019 and increases of ¥7.617 million each were reported, continuing capital raising after the listing. - FY2019AdvancedAnnual report
「This was mainly due to an increase of ¥368.566 million in retained earnings from the recognition of net income attributable to owners of the parent and an increase of ¥28.200 million in share capital and capital surplus through the exercise of stock acquisition rights, among other factors.」
During the consolidated fiscal year, the exercise of stock acquisition rights increased share capital and capital surplus by a combined ¥28.200 million, continuing capital raising after the listing. - FY2019-Q3AdvancedAnnual report
「This resulted from the exercise of share acquisition rights.」
From October to December 2018, 107,280 shares were issued through the exercise of stock acquisition rights, increasing share capital and capital reserve by ¥6.705 million each. Capital raising after the listing continued. - FY2019-Q2AdvancedAnnual report
「This was mainly due to an increase of ¥204.210 million in retained earnings from the recognition of quarterly net income attributable to owners of the parent and an increase of ¥4.800 million in share capital and capital surplus through the exercise of stock acquisition rights.」
During the six-month period of the current fiscal year, the exercise of stock acquisition rights increased share capital and capital surplus by a combined ¥4.800 million, continuing capital raising after the listing. - FY2019-Q1AdvancedAnnual report
「This was mainly due to an increase of ¥51.802 million in retained earnings from the recognition of quarterly net income attributable to owners of the parent and an increase of ¥3.140 million in share capital and capital surplus through the exercise of stock acquisition rights.」
Stock acquisition rights were exercised from April to June 2018, increasing share capital and capital surplus by a combined ¥3.140 million. - FY2018AdvancedAnnual report
「This was mainly due to an increase of ¥212.775 million in retained earnings from the recognition of net income attributable to owners of the parent and an increase of ¥26.720 million in share capital and capital surplus through the exercise of stock acquisition rights, among other factors.」
During the fiscal year, the exercise of stock acquisition rights increased share capital and capital surplus by a combined ¥26.720 million. The planned use of funds raised at the listing was changed from the development of individual tools to the development of next-generation 3A solutions and medical information systems, and the allocation timing was also changed to the fiscal years ending March 2020 and March 2021. - FY2018-Q3AdvancedAnnual report
「This was mainly due to an increase of ¥113.306 million in retained earnings from the recognition of net income attributable to owners of the parent and an increase of ¥25.250 million in share capital and capital surplus through the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased share capital and capital surplus by a combined ¥25.250 million, further advancing capital raising after the listing. - FY2018-Q2AdvancedAnnual report
「This was mainly due to an increase of ¥95.447 million in retained earnings from the recognition of quarterly net income attributable to owners of the parent and an increase of ¥12.720 million in share capital and capital surplus through the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased share capital and capital surplus by ¥12.720 million, continuing capital raising after the listing. - FY2018-Q1AdvancedAnnual report
「Net assets at the end of the first quarter of the consolidated fiscal year amounted to ¥1,130.376 million, an increase of ¥20.905 million from the end of the previous consolidated fiscal year. This was mainly due to an increase of ¥13.215 million in retained earnings from the recognition of quarterly net income attributable to owners of the parent and increases of ¥9.280 million in share capital and capital surplus through the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased share capital and capital surplus by a combined ¥9.280 million, advancing capital raising after the listing. - FY2017SoftenedAnnual report
「Investments and loans to the consolidated subsidiaries Advanced World Solutions, Inc. and 株式会社エーアイエス have not been executed in light of the subsidiaries’ funding conditions. Accordingly, changes have occurred in the timing of the investments and loans and their planned allocation at each consolidated subsidiary.」
Of the funds raised at the listing, investments and loans to subsidiaries were not executed, delaying the planned allocation of funds for test automation, product data analysis and MightyChecker development. - FY2017-Q3AdvancedAnnual report
「In addition, during the nine-month period of the consolidated fiscal year, share capital and capital reserve each increased by ¥15.710 million through payments made upon the exercise of stock acquisition rights.」
The exercise of stock acquisition rights increased share capital and capital reserve by ¥15.710 million each, further advancing capital raising after the listing. - FY2017-Q2AdvancedAnnual report
「In addition, through the issuance of 16,500 new shares in a paid-in third-party allotment with payment due on 25 July 2016, conducted in connection with an over-allotment offering, the company’s share capital and capital reserve each increased by ¥18.899 million.」
A third-party allotment carried out in connection with the over-allotment offering took place on 25 July 2016 after the listing, resulting in additional capital raising. - FY2017-Q1First statedAnnual report
「The company listed on the Mothers market of the Tokyo Stock Exchange on 21 June 2016. Through the issuance of 110,000 new shares in a public offering with payment due on 20 June 2016, conducted under the book-building method, the company’s share capital and capital reserve each increased by ¥125.994 million.」
The company reported its June 2016 listing on the Mothers market and capital raised through the issuance of new shares. The funds raised were to be used for recruitment and personnel expenses, development expenses, expansion of the enterprise solutions division, Mighty Checker upgrades and repayment of borrowings.